As part of the agreement, Prenetics has received US$30 million in cash from the sale of secondary shares to Tencent, boosting its pro forma cash and other current short-term assets 1 to over US$90 ...
Prenetics Global Limited, a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong -based early cancer detection company.